NovaBay Pharmaceuticals Files 8-K
Ticker: NBY · Form: 8-K · Filed: Oct 22, 2025 · CIK: 1389545
| Field | Detail |
|---|---|
| Company | Novabay Pharmaceuticals, INC. (NBY) |
| Form Type | 8-K |
| Filed Date | Oct 22, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, regulatory-filing, pharmaceuticals
TL;DR
NovaBay filed an 8-K on Oct 22 for an Oct 16 event - check for updates.
AI Summary
NovaBay Pharmaceuticals, Inc. filed an 8-K on October 22, 2025, reporting an event on October 16, 2025. The filing indicates "Other Events" and "Financial Statements and Exhibits" as key items. The company, incorporated in Delaware, is in the pharmaceutical preparations industry.
Why It Matters
This 8-K filing signals a material event or update from NovaBay Pharmaceuticals, Inc. that investors should be aware of, potentially impacting its stock.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for 'Other Events' and 'Financial Statements and Exhibits' without immediate indication of significant negative news.
Key Players & Entities
- NovaBay Pharmaceuticals, Inc. (company) — Registrant
- October 16, 2025 (date) — Earliest event date
- October 22, 2025 (date) — Filing date
- Delaware (jurisdiction) — State of incorporation
- 2000 Powell Street, Suite 1150, Emeryville, CA 94608 (address) — Principal executive offices
FAQ
What specific 'Other Events' are being reported by NovaBay Pharmaceuticals, Inc. on October 16, 2025?
The provided text does not detail the specific 'Other Events' beyond listing the item category.
What financial statements or exhibits are included in this 8-K filing?
The filing indicates 'Financial Statements and Exhibits' are included, but the specific contents are not detailed in this excerpt.
When was NovaBay Pharmaceuticals, Inc. incorporated and in which state?
NovaBay Pharmaceuticals, Inc. was incorporated in Delaware.
What is the principal executive office address for NovaBay Pharmaceuticals, Inc.?
The principal executive office is located at 2000 Powell Street, Suite 1150, Emeryville, CA 94608.
What is the filing date of this 8-K report?
This 8-K report was filed on October 22, 2025.
Filing Stats: 473 words · 2 min read · ~2 pages · Grade level 11.3 · Accepted 2025-10-22 16:09:13
Key Financial Figures
- $0.01 — ch registered Common Stock, par value $0.01 per share NBY NYSE American Indic
Filing Documents
- novabay_8k.htm (8-K) — 27KB
- novabay_ex3-1.htm (EX-3.1) — 110KB
- 0001829126-25-008338.txt ( ) — 323KB
- nby-20251016.xsd (EX-101.SCH) — 3KB
- nby-20251016_lab.xml (EX-101.LAB) — 33KB
- nby-20251016_pre.xml (EX-101.PRE) — 22KB
- novabay_8k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Date: October 22, 2025 NovaBay Pharmaceuticals, Inc. By: /s/ Tommy Law Name: Tommy Law Title: Chief Financial Officer 2